Hims vs Trimi for GLP-1 Weight Loss: An Honest Comparison

Pricing Comparison: What You Actually Pay

Cost is typically the most important factor for patients choosing a GLP-1 provider, and the difference between platforms can be significant over a treatment course that may last months or years. Understanding the full cost picture — not just the advertised starting price — is essential for making a sound financial decision about your weight loss treatment.

Hims weight loss programs are typically structured as monthly subscriptions that bundle the provider consultation, medication, and shipping into a single price. Their GLP-1 programs start from approximately $79 to $199 per month depending on the specific medication, dosage tier, and subscription length. Longer commitments may offer lower monthly rates. It is important to note that prices change frequently, promotional pricing may apply to initial months, and the cost may increase as you move to higher doses during the titration schedule.

Trimi takes a transparent, straightforward approach to pricing that focuses specifically on keeping GLP-1 medications affordable. Because Trimi is built entirely around GLP-1 therapy rather than operating as a general telehealth marketplace, operational costs are focused and streamlined. Trimi offers compounded semaglutide and tirzepatide options at competitive prices, with clear pricing that does not change based on subscription length or promotional windows. Patients know exactly what they will pay each month without worrying about price increases after an introductory period.

Medication Options and Sourcing

The type and quality of medication you receive is a critical factor in any GLP-1 program. Both Hims and Trimi offer compounded GLP-1 medications, but the specifics of what is available and how medications are sourced differ in important ways that patients should understand before committing to either platform.

Hims partners with compounding pharmacies to offer compounded semaglutide. As a large platform, Hims has pharmacy partnerships at scale and typically offers injectable semaglutide as part of their weight loss programs. The company has explored various formulations over time, including combination products. The specific compounding pharmacies Hims uses may vary by region and over time as their supply chain evolves with changing regulatory conditions around compounded semaglutide.

Trimi works with vetted, state-licensed 503B compounding pharmacies that meet stringent quality standards. Every compounded medication dispensed through Trimi undergoes potency and sterility testing. Trimi offers both compounded semaglutide and compounded tirzepatide, providing patients and providers with flexibility to choose the GLP-1 medication that best matches their clinical profile. This dual-medication approach is an advantage for patients who may respond better to one molecule than the other, or who may need to switch during their treatment course.

For patients specifically interested in brand-name Ozempic, Wegovy, or Zepbound, neither platform is the primary pathway — those medications are typically obtained through traditional pharmacies with insurance coverage or manufacturer savings programs. Both Hims and Trimi focus on compounded alternatives that provide the same active ingredients at substantially lower cost points. Understanding the true cost of semaglutide across all channels can help you determine which approach makes the most financial sense.

Provider Quality and Clinical Expertise

The quality of your prescribing provider matters enormously in GLP-1 therapy. Proper dose titration, side effect management, and clinical monitoring can be the difference between a successful weight loss outcome and an uncomfortable or even unsafe experience. How each platform approaches provider selection and clinical oversight shapes the quality of care you receive throughout your treatment.

Hims operates with a large and diverse provider network that covers the full range of their health categories. The providers who handle weight loss consultations may also treat patients for hair loss, skincare, or mental health conditions on the same platform. This generalist approach has the advantage of scale — Hims can typically match patients with providers quickly because they have a large pool available. However, the breadth of their practice areas means that individual providers may have varying levels of specific experience with GLP-1 medications, dosing protocols, and the nuances of metabolic weight management.

Trimi's provider network is composed of board-certified physicians and nurse practitioners who focus specifically on metabolic health and GLP-1 therapy. Because Trimi does not offer dozens of unrelated health categories, the providers on the platform develop deep expertise in weight management pharmacology. They are experienced with the specific challenges of GLP-1 dose titration — recognizing when to slow escalation due to side effects, when to hold a dose, and when to advance. This specialized focus often translates into more nuanced clinical guidance during your treatment course.

Both platforms use asynchronous consultations as their primary model, meaning you typically complete a health questionnaire that a provider reviews rather than having a live video visit for the initial evaluation. Follow-up communication models vary — patients should understand how each platform handles ongoing questions, side effect concerns, and dose adjustments throughout treatment. Trimi offers direct messaging with your care team for ongoing support and clinical questions. Learn more about the process of getting GLP-1 prescribed online.

Turnaround Time and Shipping

When you decide to start GLP-1 therapy, waiting weeks for your first dose can be frustrating and may undermine the momentum of your decision to pursue treatment. The time from initial sign-up to medication in hand varies meaningfully between platforms, and understanding these timelines can help set appropriate expectations.

On Hims, the process typically involves completing an online assessment, waiting for provider review, and then waiting for pharmacy fulfillment and shipping. The total timeline from sign-up to receiving medication can range from about one to two weeks depending on provider availability, pharmacy capacity, and shipping logistics. During periods of high demand for GLP-1 medications, these timelines can extend further. Hims ships medications via standard carriers with temperature-appropriate packaging.

Trimi is designed for speed without sacrificing clinical thoroughness. Most patients complete their health assessment in under 15 minutes, and a provider typically reviews and responds within 24 to 48 hours. Once approved, medication is shipped directly from the compounding pharmacy with cold-chain packaging to maintain medication integrity. Many patients receive their medication within days of provider approval. Trimi's streamlined focus on GLP-1 therapy means there are fewer operational bottlenecks compared to multi-category platforms that may be managing fulfillment across dozens of different medication types.

Ongoing Support and Patient Experience

GLP-1 therapy is not a one-time prescription — it is an ongoing treatment that typically requires months of dose titration, side effect management, and lifestyle adjustments. The quality of ongoing support you receive throughout this process can significantly impact both your clinical outcomes and your overall experience as a patient.

Hims provides a digital health platform with messaging capabilities and a large customer support infrastructure. As a publicly traded company with millions of customers, their support systems are built for scale. Patient experience reviews indicate that the quality of ongoing support can be variable — some patients report excellent communication with their providers, while others describe difficulty reaching their specific provider for follow-up questions or dose adjustments. This variability is not uncommon with large telehealth platforms that serve high patient volumes across many treatment categories.

Trimi's approach to ongoing support reflects its focused mission. Patients have access to their care team for questions about side effects, dosing, injection technique, and treatment planning. Because Trimi's providers work exclusively in the GLP-1 and weight management space, the support interactions tend to be more specific and clinically targeted. Patients dealing with common GLP-1 challenges — such as semaglutide side effects like nausea or constipation — can receive guidance from providers who manage these issues daily across their entire patient panel.

For patients who value a more personal clinical relationship and direct access to a provider who specializes in their specific treatment, the focused telehealth model that Trimi offers can be a meaningful advantage. For patients who prefer the comprehensive ecosystem of a larger platform and may want to manage multiple health needs in one place, Hims' breadth may be appealing.

Pros and Cons: Side by Side

To help you make a clear decision, here is an honest assessment of the strengths and limitations of each platform for GLP-1 weight loss therapy.

Hims: Strengths

Hims: Limitations

Trimi: Strengths

Trimi: Limitations

Who Should Choose Hims vs. Trimi?

The best platform for you depends on what you value most in a healthcare provider relationship and what your specific treatment needs are. Neither platform is universally better — they serve somewhat different patient profiles and priorities.

Hims may be the better fit if you already use the Hims platform for other health needs and value having everything in one place, if brand recognition and the track record of a publicly traded company are important to you, or if you are looking for a general telehealth relationship that extends beyond weight management into other health areas. Hims' broad platform can be convenient for patients who want a single login for multiple health needs.

Trimi may be the better fit if affordability is your primary concern and you want transparent pricing for compounded GLP-1 medications, if you want a provider who specializes specifically in GLP-1 therapy and metabolic health rather than a generalist, if you want the option to choose between semaglutide and tirzepatide based on your clinical needs, or if fast turnaround from consultation to medication is important to you. Trimi's focused approach typically translates to more specialized care and more competitive pricing for GLP-1 therapy specifically.

Regardless of which platform you choose, the most important thing is that you are working with a licensed provider who can properly evaluate your health history, prescribe an appropriate starting dose, guide your titration, and monitor your progress. Both Hims and Trimi meet this fundamental standard. For a comprehensive understanding of GLP-1 medications before choosing a provider, review our complete GLP-1 guide.

Understanding Compounded GLP-1 Medications

Both Hims and Trimi primarily offer compounded versions of GLP-1 medications rather than brand-name products like Ozempic or Wegovy. Understanding what compounded medications are and how they work is important context for any platform comparison in this space.

Compounded semaglutide and tirzepatide contain the same active pharmaceutical ingredient as their brand-name counterparts but are prepared by licensed compounding pharmacies rather than the original manufacturer. Compounding pharmacies operate under FDA oversight and must meet strict quality standards, particularly 503B outsourcing facilities that undergo regular FDA inspections. The compounded formulations are available at a fraction of the brand-name cost because they do not carry the research and development, marketing, and patent costs associated with brand-name products.

For a deeper understanding of the safety considerations around compounded GLP-1 medications, including how to verify pharmacy credentials and what quality testing to expect, review our detailed analysis of compounded semaglutide safety in 2026. Both platforms should be able to provide information about their pharmacy partners upon request.